SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-041709
Filing Date
2019-11-07
Accepted
2019-11-07 16:03:04
Documents
78
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 Q3 2019 10-Q srpt-10q_20190930.htm   iXBRL 10-Q 4169473
2 EX-31.1 srpt-ex311_9.htm EX-31.1 10542
3 EX-31.2 srpt-ex312_8.htm EX-31.2 11125
4 EX-32.1 srpt-ex321_6.htm EX-32.1 7193
5 EX-32.2 srpt-ex322_13.htm EX-32.2 7758
  Complete submission text file 0001564590-19-041709.txt   11768448

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA srpt-20190930.xsd EX-101.SCH 62582
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE srpt-20190930_cal.xml EX-101.CAL 86290
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE srpt-20190930_def.xml EX-101.DEF 164489
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE srpt-20190930_lab.xml EX-101.LAB 445978
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE srpt-20190930_pre.xml EX-101.PRE 330068
57 EXTRACTED XBRL INSTANCE DOCUMENT srpt-10q_20190930_htm.xml XML 2344524
Mailing Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142 617-274-4000
Sarepta Therapeutics, Inc. (Filer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-14895 | Film No.: 191200209
SIC: 2834 Pharmaceutical Preparations